Hashizume T - Search Results

1

Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.

Hasegawa Y, Nakano S, Hashizume T, Noguchi A, Ibuka K, Kasugai H, Kojima J, Ishigami S. Hasegawa Y, et al. Among authors: hashizume t. Clin Nucl Med. 1989 Jul;14(7):526-31. doi: 10.1097/00003072-198907000-00011. Clin Nucl Med. 1989. PMID: 2548797

2

[Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma].

Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Noguchi A, Kasugai H, Tanaka S, Inoue A, Kojima J, Fujita M, et al. Hasegawa Y, et al. Among authors: hashizume t. Kaku Igaku. 1992 Mar;29(3):367-76. Kaku Igaku. 1992. PMID: 1316500 Japanese.

3

Clinical study of urinary excretion of Ga-67.

Nakano S, Hasegawa Y, Ibuka K, Hashizume T, Noguchi A, Kojima J, Sasakuma F, Ishigami S. Nakano S, et al. Among authors: hashizume t. Clin Nucl Med. 1990 Apr;15(4):260-2. doi: 10.1097/00003072-199004000-00012. Clin Nucl Med. 1990. PMID: 2340660

4

Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas.

Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Sasaki Y, Imaoka S, Ishiguro S, Tanaka S, Kasugai H, Okano Y, et al. Hasegawa Y, et al. Among authors: hashizume t. Eur J Nucl Med. 1985;10(5-6):255-8. doi: 10.1007/BF00254470. Eur J Nucl Med. 1985. PMID: 2985390

5

The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.

Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Sasaki Y, Imaoka S, Ishiguro S, Kasugai H, Okano Y, Tanaka S, et al. Hasegawa Y, et al. Among authors: hashizume t. J Nucl Med. 1984 Oct;25(10):1122-6. J Nucl Med. 1984. PMID: 6090618 Free article.

6

[Changes of liver function measured by 99mTc-GSA scintigraphy after hepatectomy].

Noguchi A, Hasegawa Y, Sasaki Y, Imaoka S, Hashizume T, Ibuka K, Wakasugi S, Nakano S. Noguchi A, et al. Among authors: hashizume t. Kaku Igaku. 1995 Apr;32(4):419-26. Kaku Igaku. 1995. PMID: 7776549 Japanese.

7

[Survey for primary tumor site in patients with initial clinical presentation of bone metastasis].

Nakano S, Hasegawa Y, Ibuka K, Hashizume T, Noguchi A, Imaoka S, Komatsubara Y. Nakano S, et al. Among authors: hashizume t. Kaku Igaku. 1993 Sep;30(9):1049-54. Kaku Igaku. 1993. PMID: 8230825 Japanese.

8

Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.

Wakasugi S, Teshima H, Nakamura H, Hashizume T, Maeda T, Hiraoka A, Hasegawa Y, Masaoka T. Wakasugi S, et al. Among authors: hashizume t. Clin Nucl Med. 1998 Oct;23(10):664-71. doi: 10.1097/00003072-199810000-00004. Clin Nucl Med. 1998. PMID: 9790040

9

[A method for improving the accuracy in measurement of 99mTc-GSA liver uptake].

Noguchi A, Hasegawa Y, Hashizume T, Ibuka K, Wakasugi S, Matsunaga T, Inoue A, Sasaki Y. Noguchi A, et al. Among authors: hashizume t. Kaku Igaku. 1999 May;36(4):375-82. Kaku Igaku. 1999. PMID: 10390961 Clinical Trial. Japanese.

10

Potential of (99m)Tc-MIBI for detecting bone marrow metastases.

Wakasugi S, Noguti A, Katuda T, Hashizume T, Hasegawa Y. Wakasugi S, et al. Among authors: hashizume t. J Nucl Med. 2002 May;43(5):596-602. J Nucl Med. 2002. PMID: 11994520 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters